Matta Mario, Maltese Ludovica, Ugo Fabrizio, Di Ruocco Maria Virginia, Rametta Francesco
Cardiology Division, Sant'Andrea Hospital, Corso Mario Abbiate 21, 13100, Vercelli, Italy.
Eur Heart J Case Rep. 2021 Mar 31;5(3):ytab113. doi: 10.1093/ehjcr/ytab113. eCollection 2021 Mar.
Left atrial appendage (LAA) closure is an alternative to chronic oral anticoagulation for stroke prevention in patients with atrial fibrillation (AF) at high bleeding risk. Patients with a previous percutaneous closure of a patent foramen ovale (PFO) present an increased risk for developing AF during their life, and the presence of an atrial septal device renders future percutaneous left atrial access more challenging. Very few cases of LAA occlusion in patients with a preexisting PFO closure device have been previously reported.
A 74-years old woman was admitted to our hospital for symptomatic severe anaemia during direct oral anticoagulant treatment. Her past medical history reported an ischaemic stroke at the age of 55, at that time a PFO was diagnosed and a STARFlex™ PFO occluder (NMT Medical, Boston, MA, USA) was implanted. During the current hospitalization, the patient underwent a colonoscopy that showed colonic angiodysplasias unsuitable for endoscopic treatment and LAA closure was indicated for stroke prevention. After a multimodality pre-procedural planning that included a transoesophageal echocardiogram, a cardiac computed tomography scan and a three-dimensional cardiac model printing, the procedure was planned and the LAA successfully occluded.
LAA closure can be performed safely and effectively in patients carrying a previously implanted PFO occlusion device. In complex settings, a pre-procedural multimodality imaging is critical for improving the procedural safety and success rate. We describe the first case of percutaneous LAA closure in a patient with a prior PFO occlusion with the implantation of a STARflex™ septal occlusion device.
对于出血风险高的心房颤动(AF)患者,左心耳(LAA)封堵术是预防中风的一种替代长期口服抗凝治疗的方法。既往曾行经皮卵圆孔未闭(PFO)封堵术的患者一生中发生AF的风险增加,并且存在房间隔装置会使未来经皮左心房穿刺更具挑战性。此前仅有极少数关于已存在PFO封堵装置的患者进行LAA封堵的病例报道。
一名74岁女性在接受直接口服抗凝治疗期间因症状性严重贫血入住我院。她的既往病史显示55岁时发生过缺血性中风,当时诊断为PFO,并植入了STARFlex™ PFO封堵器(美国马萨诸塞州波士顿的NMT Medical公司生产)。在本次住院期间,患者接受了结肠镜检查,结果显示结肠血管发育异常,不适合内镜治疗,因此为预防中风而行LAA封堵术。经过包括经食管超声心动图、心脏计算机断层扫描和三维心脏模型打印在内的多模态术前规划后,制定了手术方案并成功封堵了LAA。
对于携带先前植入的PFO封堵装置的患者,可以安全有效地进行LAA封堵。在复杂情况下,术前多模态成像对于提高手术安全性和成功率至关重要。我们描述了首例在植入STARflex™ 房间隔封堵装置后发生过PFO封堵的患者行经皮LAA封堵的病例。